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Abstract 
Aims: The prevalence of alcohol-related brain damage (ARBD) is recognised to be 
increasing in the Western world. The aim of this paper is to review the evidence 
concerning interventions in ARBD.  
Design and Methods: Systematic review.  
Findings: 469 papers were identified of which 49 of which were suitable for 
inclusion. 20 concerned neuropsychological interventions; 5 detailed psychosocial 
interventions; and 24 focussed on pharmacological interventions. The findings 
suggest that a range of cognitive rehabilitation strategies can facilitate new learning 
and improve memory functioning, whilst psychosocial interventions and supported 
accommodation can improve mental and physical health  
Conclusions: This review demonstrates the need for a comprehensive approach to 
ARBD rehabilitation and indicates that the management of this condition has not 
been investigated in a holistic manner.  
   
Keywords: Alcohol-related brain damage; neuropsychology; pharmacotherapy; 
psychosocial interventions;  
 
Introduction 
In the last few decades, the prevalence of ARBD has been recognised to be 
increasing in the UK (MacRae &Cox, 2003), and it has been postulated that higher 
levels of alcohol consumption in recent years may lead to significant increases in the 
incidence of alcohol-related dementia in future generations (Gutpa & Warner, 2008). 
However as ARBD is currently under-diagnosed, estimates for the prevalence of the 
condition are thought to be imprecise (Wilson, 2013). Coupled with a lack of existing 
epidemiological data, specialist ARBD services are scarce (Thomson et al, 2012a; 
Thomson et al, 2012b; Thomson et al, 2013) and there is currently a lack of clinical 
guidance for the management of individuals with ARBD (Scottish Intercollegiate 
Guidance Network [SIGN], 2003; National Institute for Clinical Excellence [NICE], 
2011). It has been estimated that approximately 25% of individuals with ARBD will 
make a complete recovery, whilst a further 50% will recover to some degree (Smith 
& Hillman, 1999). Thus, the majority of individuals with ARBD have the potential for 
rehabilitation, providing they maintain abstinence from alcohol (Wilson, 2011). 
Despite this, the fragmented nature of services, together with the lack of clear 
pathways of care, have been recognised as major barriers to the provision of 
suitable interventions for people with ARBD (Wilson, 2011; Thomson et al, 2012b). It 
is therefore apparent that health and social care services must be improved to 
ensure that coordinated ARBD care that facilitates recovery and promotes 
independence is available to this client group (Thomson et al, 2013). 
 
ARBD is a heterogeneous condition, which affects memory and executive 
functioning and is associated with a number of comorbid health problems such as 
alcoholic liver disease, gastrointestinal problems, nutritional deficiencies, anxiety and 
depression (Cox et al, 2004; Zahr et al, 2011; Thomson et al, 2012b). The impact of 
ARBD is multifaceted and includes impairments in a number of domains, including 
cognitive, psychosocial and behavioural functioning (Kopelman et al, 2009). Despite 
this, the lack of integration between within health and social care services can result 
in people with ARBD becoming ‘stuck’ within a particular type of service that does 
not comprehensively address all of their needs (Cox et al, 2004). A multidisciplinary 
approach is therefore required to ensure that services offer client-centred 
interventions that are tailored to meet the varying needs of individuals with ARBD in 
a holistic way (Kopelman et al, 2009).  
 
The highest prevalence of ARBD is found in people between the ages of 50 and 60 
years old (MacRae & Cox, 2003). Moreover, anecdotal evidence from practitioners in 
the field suggests that the age of onset for ARBD may be reducing. Whilst the 
majority of individuals diagnosed with ARBD can be expected to improve to some 
degree, it is estimated that around 25% will require on-going residential care or 
access to supported accommodation services (Smith & Hillman, 1999; Cox et al, 
2004). However, a report by the Mental Welfare Commission for Scotland (2010) 
demonstrated that mainstream care homes for older people do not adequately meet 
the needs of people with ARBD. In particular, traditional care homes for older people 
may offer little opportunity for rehabilitation, which can lead to further functional 
losses and exacerbate co-morbid mental and physical health problems in people 
with ARBD (Wilson et al, 2012). Moreover, Kopelman et al (2009) argued that 
dementia services are not equipped to meet the needs of younger adults with ARBD. 
It can therefore be argued that the provision of age-appropriate ARBD specific 
residential care should be a priority within ARBD rehabilitation services. 
 
The Arbias (2011) ‘Looking Forward’ handbook recommends the implementation of 
individualised intervention strategies for people with ARBD which incorporate 
techniques to address memory impairment and executive dysfunction, whilst 
promoting healthy eating, supporting positive behaviours and facilitating 
independence. Consistent with these recommendations, a number of specialist 
ARBD services have been set up within Scotland (Thomson et al, 2012b). The aim of 
this paper is to systematically review the evidence concerning ARBD interventions to 
enable us to make recommendations for best practice within ARBD rehabilitation 
services. This review will provide an overview of the range of interventions currently 
available for individuals with ARBD. Moreover, it will identify gaps in the evidence-
base and highlight areas for future research. This review is underpinned by a holistic 
person centred philosophy of care. Thus, it will focus on identifying a comprehensive 
range of interventions, which can be tailored to meet the needs of individual service 
users.      
 
Method 
An online database search was conducted on July 18 2013. The following online 
databases were searched to identify English language journal articles focussing on 
interventions for ARBD: CINAHL Plus with Full Text; Health Source: 
Nursing/Academic Edition; MEDLINE; Psychology and Behavioral Sciences 
Collection; PsycINFO. Please see Figure 1 for a PRISMA Flow Diagram depicting 
the literature search strategy (Moher et al, 2010). No date limitations were set in 
order to identify all relevant online publications and search terms included: alcohol-
related brain damage/Korsakoff*/ Korsakoff’s syndrome/Wernicke-Korsakoff” AND 
intervention*/treatment/rehabilitation.  
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The database search revealed a total of 469 references. Once duplicates had been 
removed, 366 references remained. Two-hundred and sixty-five of these references 
were excluded, leaving a total of 101 abstracts to be screened for inclusion in the 
review. The identified papers were screened according to the following inclusion and 
exclusion criteria:  
 
Inclusion Criteria: 
1. Primary research study, literature review  
2. Human participants study 
3. English Language paper 
4. Participants have Korsakoff’s syndrome 
5. Papers focus on interventions rather than diagnosis or assessment of ARBD 
 
Exclusion Criteria: 
1. Animal studies 
2. Acute treatment for Wernicke’s encephalopathy  
3. Letter, descriptive paper 
4. Book reviews 
5. Article focusses on the prevention of Wernicke-Korsakoff’s syndrome 
6. Article focusses on participants in the acute Wernicke’s encephalopathy 
stage 
 
Of the 101 abstracts screened, 28 were excluded as they were not relevant to this 
review. Seventy-three articles remained. As 1 of these papers was unobtainable, 72 
were screened for eligibility. Thirty-two of these papers did not meet the inclusion 
criteria, leaving a total of 40 articles to be included in the review. A further online 
search conducted on August 28 2013 identified one additional paper for inclusion in 
the current review (Svanberg & Evans, 2013). An additional 8 relevant papers were 
identified within Svanberg and Evans’ paper, and these papers have been 
incorporated into the current review. This left a total of 49 articles to be included in 
the current review: Twenty of the papers concerned neuropsychological 
interventions, whilst 5 focussed on psychosocial interventions and 24 detailed 
pharmacological treatments for ARBD.  The third author corroborated the findings of 
the search conducted by the first author through replication of the search strategy, 
detailed review of abstracts screened, and review and discussion of included papers 




Table 1. presents details of the neuropsychological and psychosocial interventions 
identified within this review. The majority of the neuropsychological intervention 
strategies focussed on the use of cognitive rehabilitation techniques to improve 
cognitive functions such as memory and executive functioning. A range of memory 
rehabilitation techniques were identified including rote learning; visual imagery; cued 
learning; verbal mediation; semantic and elaborative processing; ‘imprinting’ using 
paired associates learning; differential outcomes training; errorless learning; effortful 
learning; self-performed tasks and reality orientation. Compensatory strategies were 
also identified as a means of supporting residual memory function and compensating 
for cognitive impairments. Furthermore, executive functioning was targeted using 
strategies such as rule provision; decision-making and initiative training; and mental 
flexibility training. As Svanberg and Evans (2013) recently reviewed the evidence for 
neuropsychological ARBD interventions, the papers included in their review have 
been marked with an asterisk in Table 1.   
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Memory Rehabilitation Techniques 
Cermak (1975), Goldstein and Malec (1989) and Kashima et al (1998) focused on 
the use of rote learning as a means of facilitating the learning and retrieval of specific 
information in patients with Korsakoff’s Syndrome (KS). The findings from these 3 
studies were variable, with Kashima et al (1998) and Goldstein and Malec’s (1998) 
findings suggesting that the use of simple repetition is effective in training KS 
patients to remember specific information, whilst Cermak’s (1975) findings indicated 
that rote learning was less effective than visual imagery and cued learning in 
facilitating KS patients’ retrieval of verbal information. As there was no control group 
or comparison intervention in Kashima et al’s (1998) study, their findings provide no 
evidence to indicate how effective simple repetition is in comparison to other 
strategies. Thus, Cermak’s (1975) finding that rote learning was less effective than 
visual imagery and cued learning appears to be of greater value.  
 
Cermak (1975; 1980) investigated the effectiveness of visual imagery and cued 
learning as memory improvement strategies for 6 KS patients. Cermak’s findings 
indicated that the use of mental visualisation was more effective than either cued 
learning or rote learning in facilitating memory for verbal information. However, 
Cermak stated that these strategies were unlikely to result in the long-term retention 
of information. Moreover, the generalizability and clinical applicability of Cermak’s 
findings can be questioned, due to the small sample size and experimental nature of 
the studies. In a more applied study, Heinrichs et al (1992) used letter-fragment 
cueing to enable a hospitalised KS patient to learn and remember their activity 
schedule within the ward. Cueing was found to be an effective learning strategy, as it 
enabled the patient to respond spontaneously to unanticipated changes in the ward 
schedule and also showed potential as a transferable strategy, which could be used 
in other learning tasks. However, Heinrichs et al’s findings may also be of limited 
generalizability as they are based on a single participant.    
 
Cermak (1980) also investigated the use of verbal mediation and the semantic 
analysis of words as memory improvement strategies for 6 KS patients. The use of 
verbal labels in this study was found to improve the retention of random shapes, 
whilst analysing the meaning of words was found to facilitate their retrieval. 
Consistent with this, Van Damme and d’Ydewalle (2008) provided further evidence 
for the effectiveness of semantic processing, as elaborative processing of semantic 
information was found to improve 8 KS patients’ memory to the level of healthy 
controls. Svanberg and Evans (2013) noted that Van Damme and d’Ydewalle’s study 
provided the highest level of evidence and recommended that individuals with ARBD 
should be given support to make explicit associations during learning tasks, as well 
as being provided with rule explanations, and extra processing and retrieval time.  
 
Hochhalter et al (2000) and Hochhalter and Joseph’s (2001) studies demonstrated 
that differential outcomes training improved face recognition in 4 KS patients. During 
the differential outcomes procedure, participants learned to associate specific 
reinforcers with particular faces, as they were given a coin each time they correctly 
identified one face, whereas they were given a point for correctly identifying another 
face. The findings from these studies suggest that the principles of operant 
conditioning can be used to promote memory improvements in ARBD. Moreover, 
Hochhalter and Joseph (2001) stated that differential outcomes training may have 
real-world applications. Nonetheless, there is currently a lack of evidence to indicate 
how the differential outcomes procedure can be implemented effectively within 
clinical settings.  
 
Another memory improvement strategy which may have therapeutic potential within 
an ARBD rehabilitation context is the use of self-performed tasks (SPTs; Mimura et 
al, 1998; Mimura et al, 2005). Mimura et al (1998) compared the effect of STPs and 
verbal tasks (VTs) on memory performance and demonstrated that a sample of 8 KS 
patients remembered action phrases, such as ‘bounce the ball,’ significantly better 
when they enacted them during encoding. A more recent study by Mimura et al 
(2005) investigated the impact of self-generated SPTs, which involved 8 KS patients 
verbally generating their own action phrases and then performing them. The findings 
from Mimura et al’s (2005) study also indicated that the physical enactment of verbal 
instructions resulted in better recall and recognition than when participants simply 
listened to the action phrases. Moreover, as self-generated SPTs also facilitated the 
recall of information, Mimura et al’s (2005) findings have implications for real-life 
situations where the actions to be performed are chosen by the individual 
themselves, rather than being predetermined by another person. Consistent with 
this, Svanberg and Evans (2013) noted that self-generation and enactment may 
facilitate personal goal setting during client centred interventions.  
 
Wilson et al (1994), Komatsu et al (2000) and Kessels et al (2007) compared the 
impact of errorless learning and trial-and-error learning on electronic aid 
programming, face-name association and route learning. Wilson et al (1994) found 
that errorless learning improved 5 KS patients’ ability to programme the electronic 
device, whilst Komatsu et al (2000) demonstrated better name-face recall when 
errorless learning was used with 8 KS patients. In contrast, Kessels et al (2007) 
found no advantage of errorless learning over trial and error learning during a route 
learning task, which involved training10 KS patients to remember pre-determined 
routes within the grounds of a hospital. The findings from these 3 errorless learning 
studies were inconsistent and suggest that errorless learning may facilitate the 
effective use of assistive technology, as well as enhancing the ability to remember 
names and faces, whilst it may be of limited therapeutic value during spatial 
procedural learning tasks. Accordingly, Svanberg and Evans (2013) concluded that 
errorless learning techniques may be more beneficial during verbal rather than 
spatial tasks.  
 
Woods (1983) described a Reality Orientation (RO) approach, which was used to 
reduce levels of confusion and reorient one 68-year old female with KS to personal 
and non-personal information. Twice daily individual training sessions within a 
hospital context resulted in improved scores on a personalised memory and 
information test, demonstrating that the patient was able to learn specific information 
that was taught within the RO sessions. Nevertheless, the participant’s learning had 
limited generalizability beyond the information that was taught. Moreover, the extent 
to which the observed improvements could be attributed to rote learning, clues or 
memory prompts was recognised to be unclear, indicating that the mechanisms by 
which the RO sessions were effective were ambiguous. 
 
Interventions for Executive Dysfunction 
Three papers focussed on strategies to improve executive functioning in ARBD. 
Bardenhagen et al, (2007) investigated the impact of four different types of rule 
provision on the performance of 10 males with KS during a rule induction task. The 
rule induction task involved using a modified Wisconsin General Testing Apparatus 
(WGTA), which is a wooden stimulus board with an opaque screen. Success was 
achieved when participants learned the implicit rule which enabled them to correctly 
determine the location of rewards on the stimulus board. The findings from this study 
indicated that performance was best when participants were provided with both 
alternation rules and correction rules. These findings suggest that rule knowledge is 
essential to reducing errors on delayed alternation and object alternation tasks. 
Moreover, Bardenhagen et al proposed that poor performance during rule induction 
tasks is due to impaired problem solving ability, rather than simply reflecting an 
inability to inhibit preservative errors. Svanberg and Evans (2013) asserted that the 
clinical applicability of Bardenhagen et al’s findings are ambiguous. However, they 
suggested that the provision of clear rules to individuals with ARBD during 
rehabilitation may reduce the incidence of preservative errors and help to structure 
tasks during everyday problem solving activities.  
 
Monteiro et al (2011) incorporated decision-making and initiative training within a 
neuropsychological intervention programme for a single ARBD patient. A graded 
approach was adopted using increasingly complex real-life scenarios, such as 
choosing clothes, establishing daily routines, grocery shopping, and bill payment. 
Decision-making and initiative training was reported to increase the patient’s level of 
daily autonomy and independence. Nevertheless, the strategies used to achieve 
these improvements are unclear. In the third study addressing executive functioning, 
Diamant and Huijsman, (1982) used mental flexibility training to reduce behavioural 
rigidity in a single KS patient. Diamant and Huijsman also trained psychomotor 
speed and memory, using tapping and peg board tests and paired associates 
learning. However, as the patient withdrew from this study prematurely, the duration 
of the reported improvements is unknown. As both of these papers were single case 
studies, the strength of their findings is limited.    
 
Compensatory Strategies 
External memory aids were used to compensate for impairments in cognition and 
memory in the papers by Davies and Binks (1983), Lenanne (1986), Morgan et al 
(1990) and Montiero et al (2011). In Montiero et al’s study, the use of personal 
journals facilitated access to newly acquired personally meaningful information and 
also improved temporal orientation. Moreover, Davies and Binks (1983) reported that 
the use of prompt cards and notebooks reduced one patient’s levels of anxiety and 
social embarrassment. The benefits associated with using memory aids were not 
specifically addressed by Lenanne (1986). Nevertheless, participants used a 
memory-aid book, which they carried in a bag to record information they had 
difficulty remembering. Morgan et al (1990) found that a programmable electronic 
diary had no added value in improving one patient’s attendance at inpatient 
occupational therapy groups. As the electronic diary was introduced following the 
successful use of verbal staff prompts and other compensatory strategies, no 
evidence was obtained for the potential impact of assistive technological devices 
when used in the absence of alternative compensatory strategies.     
      
Psychosocial Interventions     
Limited evidence was found for the use of psychosocial ARBD interventions, as only 
five papers focussed on improving this aspect of functioning (Table 1). A recent 
descriptive study by Wilson et al (2012) presented information about a phased 
psychosocial rehabilitation programme for individuals with ARBD living in the 
community, which aimed to enhance self-efficacy, independence and the 
development of life-skills. Particular intervention strategies included psychological 
therapies, social support and the implementation of structured activity schedules to 
establish daily routines. This programme was reported to be effective in promoting 
positive clinical outcomes, such as reducing acute hospital admissions and relapse 
rates, whilst it also improved cognitive functioning and the living environments of 
service users. Lenanne (1986) and Monteiro et al (2011) demonstrated that the 
implementation of fixed daily routines, along with participation in alcohol-free 
recreational activities can increase levels of independence and spontaneity in 
individuals with ARBD. Moreover, Blansjaar et al (1992) and Irvine and Mawhinney 
(2008) provided evidence to suggest that specialist supported accommodation is 
beneficial in ARBD rehabilitation, as it facilitated independence as was associated 
with improvements in social, physical and behavioural functioning. A case study by 
Morrison and Pestell (2010) provided further evidence for the importance of 
psychosocial ARBD interventions, as an adapted cognitive-behavioural approach 
enabled the patient to challenge their unhelpful thoughts and assumptions and 
modify their behaviour, and resulted in improved mood. However, no firm 
conclusions can be drawn from these studies, due to methodological limitations such 
as small sample sizes and the descriptive nature of the psychosocial papers.  
 
Pharmacological Treatments 
A total of 12 different types of pharmacological treatment were identified within the 
24 pharmacological papers (See Table 2.). 
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B-Complex Vitamins 
Ten papers focussed on the role of B-complex vitamins in the treatment of ARBD 
and thiamine was the most commonly occurring pharmacological treatment to be 
identified. The identified papers reported a range of doses and durations of B-
complex vitamin treatment, with a recent systematic review presenting evidence to 
suggest that 200mg of thiamine administered daily for two days was effective in 
improving learning and memory in WKS patients (Day et al, 2013), whilst two 
reviews by Cook and Thomson (1997) and Cook (2000) indicated that high-potency 
parenteral B-complex vitamins should be administered for 3-5 days in the prevention 
of WKS, and for 1 week in the treatment of WKS. A case study by Carota & 
Schneider (2005) indicated that 600mg of thiamine administered daily 4 months after 
the initial diagnosis of WKS facilitated ‘dramatic’ neurological and cognitive recovery. 
However, Leigh et al’s (1981) study demonstrated that the administration of thiamine 
and/or the thiamine derivative thiamine tetrahydrofurfuryldisulphide (TTFD) to 24 
WKS patients over varying time periods of six weeks to two years had no beneficial 
effects on cognitive functioning. 
 
The oral absorption of thiamine can be considerably impaired in WKS patients. Thus, 
the papers included in this review indicate that B-complex vitamins should be 
administered parenterally rather than orally (Cook & Thomson, 1997; Cook, 2000; 
Thomson et al, 2013). Consistent with this, current NICE guidelines recommend that 
high doses (500mg) of intravenous B-complex vitamins in the form of Pabrinex 
should be administered 3 times daily for 2-3 days in the treatment of acute 
Wernicke’s Encephalopathy, followed by 100mg of oral thiamine three times daily 
during post-acute hospitalisation and outpatient treatment (Thomson et al, 2012b). 
One possible contraindication of the use of B vitamins in the treatment of Wernicke-
Korsakoff’s syndrome is the risk of anaphylaxis following parenteral administration of 
thiamine (Cook, 2000; Day et al, 2013). Nevertheless, the risk of anaphylactic shock 
is reported to be extremely low and the benefits of administering parenteral B-
complex vitamins are recognised to outweigh the potential risks (Cook and 
Thomson, 1997; McIntosh et al, 2005). It is also recommended that parenteral B-
complex vitamins, infused in 50-100ml of saline, should be administered slowly over 
a 15-30 minute time period, to reduce the risk of allergic reaction (Cook, 2000; 
Thomson et al, 2012b). 
 
Acetylcholinesterase Inhibitors 
Three of the pharmacological papers investigated the role of acetylcholinesterase 
inhibitors in the treatment of WKS (Iga et al, 2001; Cochrane et al, 2005; Luykx et al, 
2008). Acetylcholinesterase inhibitors such as donepezil and rivastigmine are used 
in the treatment of Alzheimer’s disease and act to increase the availability of the 
neurotransmitter acetylcholine, which plays an important role in the cortical-
hippocampal system, the neural substrate of memory (Luykx et al, 2008). Both Iga et 
al (2001) and Cochrane et al (2005) presented evidence to indicate that donepezil is 
effective in the treatment of ARBD. The case report by Iga et al (2001) demonstrated 
that the administration of donepezil following unsuccessful thiamine and fluvoxamine 
treatment was effective in reducing amnesia in a 46 year old female patient with 
Korsakoff’s syndrome. Furthermore, daily doses of 3mg Donepezil for 1 week, 
followed by 15mg of donepezil thereafter, resulted in improvements in cognitive 
functioning and quality of life (Iga et al, 2001). Consistent with these findings, 
Cochrane et al (2005) reported improvements in cognitive functioning in three WKS 
patients as a result of 6 to 8 months of donepezil treatment. Improvements in 
patients’ subjective wellbeing and the ability to think clearly were also reported. In 
contrast, Luykx et al (2008) found that rivastigmine administered to five WKS 
patients over 6 months had no significant impact on cognitive functioning. Although 
slight memory improvements were found following rivastigmine treatment, the effects 




Two papers examined the effectiveness of the selective serotonin reuptake inhibitor 
fluvoxamine in the treatment of WKS (Martin et al, 1989; O’Carroll et al, 1994).  
Martin et al (1989) compared fluvoxamine administered in doses ranging from 
100mg to 200mg per day to a placebo in a 4-week double-blind cross-over trial. This 
study included a sample of 6 KS patients, 3 patients with dementia associated with 
alcoholism and 1 patient with alcoholic liver disease. Fluvoxamine treatment was 
found to improve episodic memory in KS patients only, a finding which Martin et al  
(1989) suggested may be indicative of an underlying deficit in serotonergic activity in 
patients with KS. Nevertheless, the findings from O’Carroll et al’s (1994) subsequent 
double-blind cross-over trial were inconsistent with Martin et al’s (1989) results, as 
200mg of fluvoxamine per day was found to have no advantage over placebo in 
terms of improving cognitive functioning in a sample of 8 KS patients. O’Carroll et 
al’s findings were also incompatible with the serotonergic dysfunction hypothesis 
highlighted by Martin et al (1989), as two of the participants in O’Carroll et al’s study 
were reported to develop symptoms of clinical depression whilst taking fluvoxamine. 
The discrepant nature of these findings suggests that fluvoxamine may be of little 
therapeutic value in improving cognitive function in patients with ARBD. However, 
further research is warranted to investigate the role of selective serotonin reuptake 
inhibitors in the treatment of this condition.  
 
Other drug treatments  
There was limited evidence to suggest that methylphenidate (O’Donnell et al, 1986); 
memantine (Rustembegovic et al, 2003); DL-threo-3,4-dihydroxyphenylserine 
(DOPS; Langlais et al, 1988); propranolol (Yudofsky et al, 1982)  and clonidine 
(Ferrin, 1993; O’Carroll et al, 1993) have a role in the pharmacological treatment of 
ARBD. O’Donnell et al (1986) found improvements in long-term memory following 
the administration of the norepinephrine-dopamine reuptake inhibitor, 
methylphenidate to 6 KS patients. However, the impact of the drug was not 
immediate and no short-term memory improvements were found. Moreover, 
although O’Carroll et al (1993) found no advantageous effect of clonidine on 
cognitive functioning, Ferrin (1993) reported evidence to suggest that it is beneficial 
in reducing anterograde amnesia. Rustembegovic et al (2003) found that 
administration of the N-methyl-D-aspartate (NMDA) antagonist, memantine resulted 
in improved cognitive functioning in 16 KS patients. However, Rustembegovic et al 
screened cognitive functioning using the Mini Mental State Examination (MMSE) 
rather than a comprehensive neuropsychological test battery, and no other papers 
investigated the role of NMDA, indicating that the strength of these findings was 
weak.   
 
Langlais et al (1988) found limited evidence for the effectiveness of DOPS, which 
acts on the neurotransmitters noradrenaline and adrenaline, as it improved 
performance on the Memory Passage subtest of the Wechsler Memory Scale (WMS) 
only. Moreover, Yudofsky et al (1982) found that the sympatholytic non-selective 
beta blocker, propranolol resulted in the reduction in rage and violent behaviour in 
one male KS patient. However, as this study was based on a single patient 
displaying frequent violent behavioural outbursts, this finding may not be 
generalizable to other individuals with ARBD. There was no evidence within this 
review to suggest that Desglycinamide Arginine Vasopressin (DGAVP; Jennekins-
Schinkel et al, 1985); Physostigmin (O’Donnell et al, 1986); Reboxetine (Reuster et 
al, 2003) and Rivastgmine (Luykx et al, 2008) should be used to treat patients with 
ARBD. 
Discussion 
This review examined the evidence for ARBD interventions, with the principle aim of 
informing practice within ARBD rehabilitation services. The range of interventions 
and treatments identified within this review reflects the multifaceted nature of ARBD 
and highlights the need for a comprehensive approach to the management of this 
condition (Cox et al, 2004; Kopelman et al, 2009). Nevertheless, the disproportionate 
number of pharmacological and neuropsychological papers identified within the 
review indicates that research into psychosocial interventions for ARBD has 
historically been sparse, and suggests that previous research in this area has 
focussed mainly on treating the medical and cognitive aspects of ARBD. The lack of 
integration between neuropsychological, psychosocial and pharmacological research 
suggests that the management of individuals with ARBD has not been investigated 
in a holistic manner.  
 
A range of neuropsychological interventions were identified within this review, 
including memory rehabilitation techniques, methods of addressing executive 
dysfunction and compensatory strategies. As the neuropsychological studies were 
mainly experimental, the findings presented within this review may have limited 
ecological validity, clinical applicability. Moreover, the small sample sizes limits the 
generalizability of these findings. Ten of the papers included in this review were 
single-subject case studies. This represents a significant weakness within the 
contemporary evidence base as it limits the extent to which the studies can be used 
to make evidence-based recommendations in terms of generalisability. As less than 
half of the neuropsychological papers were published within the last decade, it is 
clear that the evidence base for neuropsychological ARBD interventions needs 
updating. These limitations notwithstanding, the findings indicate that cognitive 
rehabilitative strategies can facilitate new learning and alleviate anterograde 
amnesia in individuals with ARBD.  
 
The strongest evidence was found for the following cognitive rehabilitative strategies: 
visual imagery (Cermak, 1975; Cermak, 1980); elaborative and semantic processing 
(Cermak, 1980; Van Damme & d’Ydewalle, 2008); self-performed and self-generated 
tasks (Mimura et al, 1998; Mimura et al, 2005); errorless learning during verbal tasks 
(Wilson et al, 1994; Komatsu et al, 2000); and rule provision during problem solving 
(Bardenhagen et al, 2007). It is therefore recommended that individuals with ARBD 
should be supported to make visual and semantic associations during learning. 
Practitioners should also provide explicit instructions and additional processing and 
retrieval time, as well as preventing individuals from making errors during learning. 
Individuals with ARBD should be encouraged to physically enact instructions and 
formulate their own treatment goals. Memory aids and environmental modifications 
should also be used in the rehabilitation of ARBD, as they can improve daily 
functioning and may reduce the anxiety and social embarrassment associated with 
memory impairment (Davies & Binks, 1983; Lenanne, 1986; Morgan et al, 1990; 
Monteiro et al, 2011).  
 
Limited evidence was found for psychosocial ARBD interventions and the existing 
psychosocial evidence was of limited quality, due to methodological weaknesses and 
small sample sizes. Nonetheless, the findings from this review indicate that a variety 
of psychosocial interventions are beneficial in the rehabilitation of ARBD. It is 
therefore recommended that practitioners should deliver structured group and 
individual psychosocial interventions which focus on establishing regular daily 
routines, such as self-care habits, regular meal times and participation in timetabled 
activities, within an alcohol-free environment (Lenanne, 1986; Monteiro et al, 2011; 
Wilson et al, 2012). Many individuals with ARBD may be socially isolated (MacRae & 
Cox, 2003). Thus, it is also recommended that psychosocial interventions should 
focus on promoting family involvement, as well as encouraging the development of 
social support networks by facilitating engagement in meaningful social activities 
(Wilson et al, 2012). The reviewed evidence suggests that ARBD interventions 
should take place within supported accommodation facilities, as Blansjaar et al 
(1992) and Irvine and Mawhinney (2008) highlighted the potential value of specialist 
residential rehabilitation in enhancing social and behavioural functioning and 
improving physical and mental health. Morrison and Pestell, (2010) demonstrated 
the potential value of cognitive-behavioural interventions in promoting recovery from 
ARBD. However, these authors noted that cognitive restructuring techniques may be 
problematic within ARBD rehabilitation, due to impaired memory and issues with 
abstract thought. It is therefore suggested that low intensity behavioural strategies, 
such as behavioural activation may be more beneficial in the psychosocial 
rehabilitation of ARBD (Williams & Martinez, 2008).   
 
A number of pharmacological ARBD treatments were identified within this review, 
including thiamine and B-complex vitamins; acetylcholinesterase inhibitors; 
fluvoxamine and a number of other drugs for treating memory impairment. Due to 
small sample sizes, inconsistent results and the small number of up to date 
pharmacological studies, the evidence for the pharmacological management of 
ARBD is inconclusive. The most extensive evidence was found for thiamine 
treatment, with ten papers focused on the treatment of ARBD with thiamine and B-
complex vitamins. Therefore, as Wernicke-Korsakoff’s Syndrome (WKS) is primarily 
caused by thiamine deficiency (Isenberg-Grzeda et al, 2012), and as vitamin B6 and 
B12 deficiencies can also impair the absorption of thiamine in chronic alcoholics 
(Thomson et al, 2012b), the administration of B-complex vitamin supplements along 
with sufficient intake of dietary nutrients, is recommended in the long-term 
management of ARBD (Arbias, 2011). Nevertheless, there is currently no 
standardised protocol concerning the dosage, frequency and route of thiamine 
treatment for WKS and there is a recognised lack of conclusive evidence concerning 
the optimum duration of thiamine treatment in the long-term management of ARBD 
(Sum & Brody, 2012; Day et al, 2013). Moreover, as current clinical guidelines are 
based on the findings from basic science, case reports and methodologically weak 
research papers rather than robust evidence from double-blind randomised control 
trials (Sum & Brody, 2012; Day et al, 2013), the therapeutic value of B-complex 
vitamin supplements in the pharmacological management of ARBD is unclear.  
 
This review has highlighted the need for more research into the comprehensive 
rehabilitation of individuals with ARBD. It can be argued that methodologically robust 
randomised control trials (RCTs) investigating the efficacy of specific rehabilitation 
strategies may be of limited clinical relevance (Mantzoukas, 2008), as the ecological 
validity of RCT findings may be compromised. Consistent with this, Svanberg and 
Evans (2013) asserted that single case experimental studies offer a potentially 
fruitful means of advancing what is known about effectiveness of individual 
components of ARBD interventions. It is therefore recommended that applied 
longitudinal research employing both quantitative and qualitative research methods 
should be conducted, to close the gap between theory and practice and to gain a 
rich understanding of the therapeutic value of specific intervention strategies within a 
holistic model of ARBD care.  
Implications for practice 
Nurses, doctors and allied health professionals have a critical role in the provision of 
high quality care for ARBD and an understanding and appreciation of the 
contemporary evidence base in interventions in this area is critical to foster patient 
centred and high quality care.  This review suggests that ARBD interventions should 
include a combination of cognitive rehabilitation techniques; compensatory strategies 
for memory impairment; psychosocial interventions and pharmacological treatments.  
Despite the limitations noted above, the findings from this review are consistent with 
the practice recommendations outlined by Arbias (2011). Due to the focussed nature 
of our search strategy, it is possible that this review has not captured all of the 
relevant evidence concerning interventions that may be of relevance to the 
rehabilitation of individuals with ARBD. Moreover, due to the existence of comorbid 
mental and physical health problems, (Cox et al, 2004; Zahr et al, 2011; Thomson et 
al, 2012b) it is possible that additional relevant intervention strategies may exist 
within the broader research literature. It is nevertheless clear that the body of 
research concerning comprehensive ARBD specific interventions is in its infancy. 
The scale of the studies reviewed within this paper is very small. The scarcity of the 
existing evidence is problematic as it suggests that the findings may not be 
generalizable and also indicates that the size of the evidence-base is currently 
incongruous with the increasing prevalence of ARBD. Further research is therefore 
warranted to ensure that ARBD rehabilitation services are evidence-based and meet 
service users’ needs in all relevant domains.   
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Table 1: Neuropsychological and psychosocial interventions for ARBD  
Intervention Number of 
papers 
Number of  
Case Studies 





0 Use of repetition to facilitate learning and retrieval of information Findings were inconsistent. Rote rehearsal improves memory for specific 





0 Use of visualisation to create images associated with verbal 
information. 
Visual imagery was more effective than cued and rote learning and 




 [3,8*, 21]  
 
0 Semantic cues (Cermak, 1975) and letter-fragment cueing (Heinrichs et 
al, 1992) were used to aid the retrieval of information.  
 
Cueing improved performance, but was not as effective as visual imagery in 
facilitating memory (Cermak, 1975). Cueing enabled KS patient to learn 
activity schedule, develop self-cueing skills and improve temporal 
orientation. Benefits were generalizable to tasks that were not specifically 
trained (Heinrichs et al, 1992). 
Verbal mediation 1  
[4] 





[4, 21, 22*]  
0 Use of conceptual and contextual knowledge to aid retrieval of 
information.  
Semantic analysis facilitated word retrieval when 12-item word lists were 
used (Cermak, 1980). KS patients were able to process elaborative, 
semantic information as well as controls if given additional time, 




[9*, 10*, 21] 
0 Conditioning procedure using consistent and specific 
outcomes/reinforcers in conjunction with specific discriminative 
stimuli. 
Accuracy for remembering faces was markedly better during differential 
outcomes training than during non-differential outcomes training.  
Errorless learning 
/ 





0 Errorless learning prevents opportunities for making errors whilst 
learning, whilst trial and error learning provides opportunities to make 
errors and learn from previous mistakes whilst learning. 
Findings were inconsistent. Errorless learning improved performance on a 
variety of tasks, including learning the names of people and objects, 
programming an electronic aid, remembering orientation items and 
acquiring new general knowledge.  However, it was no more successful 
than trial and error learning on a spatial procedural route-learning task.  




0 Effortful learning involves effortful cognitive processing, whilst 
effortless learning does not.  
Memory was enhanced during a modified version of the vanishing cues 
method, which was designed to reduce errors whilst still requiring effortful 
cognitive processing.   
Self-performed 
tasks / verbal tasks 
3 
 [16*, 17*,21] 
0 Self-performed tasks (SPTs) involve listening to action phrases and 
subsequently performing the actions, whilst verbal tasks (VT) involve 
listening to action phrases without enacting them.  






0 Self-generated SPTs involve verbally generating an action phrase and 
then performing the action, whilst self-generated VTs involve verbally 
generating an action phrase without performing it.  
Self-generation facilitated recognition whether or not the action phrase was 
enacted, whereas recall was enhanced only when self-generated action 
phrases were enacted.   
Reality orientation 1 
 [25]  
1 [25] Presentation of information to reorient individuals to their environment 
and reduce levels of confusion.  
Reality orientation sessions resulted in improved scores on a memory and 
information test.   
Rule provision 2 
 [1*,21] 
0 Alternation rules and/or correction rules were provided during delayed 
alternation (DA) and object alternation (OA) tasks to facilitate rule 
induction and response inhibition. 






1 [18] Training was delivered to improve performance on increasingly 
difficult real-life activities, including making food choices, scheduling 
activities, establishing self-care habits, grocery shopping and paying 
bills.   
Observed behavioural changes included spontaneous initiation of self-care 
tasks, use of memory aids, increased independence at home, and improved 






1 [6] 14-week training program aiming to increase psychomotor speed 
(assessed using Purdue peg board and tapping test), imprinting (using 
paired associates learning) and mental flexibility (assessed with test of 
behavioural rigidity). 
Improvements were found in ‘most’ trained functions. Imprinting/memory 






3 [5, 18, 19] Use of notebooks, calendars, diaries, photography, lists, prompting, 
assistive technology and environmental modifications to compensate 
for cognitive and memory impairments.  
Compensatory memory strategies supported residual memory, facilitated 
access to newly acquired autobiographical information, improved temporal 
orientation, enabled self-monitoring of daily activities and reduced social 




[2*, 11, 21]  
0 Nursing home, specialist supported accommodation Findings were variable, but suggest that specialist accommodation can 
improve social functioning, promote family involvement, facilitate 
participation in meaningful activities, encourage abstinence, improve skills 
in activities of daily living, and improve physical and mental health.     
Psychosocial 
rehabilitation  
4   
[15,18*,  21, 
24*] 
1 [18] Psychosocial rehabilitation strategies included stabilisation, 
establishment of daily routine, skill acquisition, problem solving, 
nutritional maintenance, social integration and relapse prevention.  
Key outcomes of psychosocial rehabilitation included reduced acute 
hospital admissions, abstinence from alcohol, placement in appropriate 
accommodation, improved cognitive and behavioural functioning, reduced 
social isolation, increased independence, acquisition of skills, and improved 
mental and physical health.      
Papers: *Bardenhagen et al, 2007 [1]; *Blansjaar et al, 1992 [2]; Cermak, 1975 [3]; Cermak, 1980 [4]; Davies and Binks, 1983 [5]; Diamant and Huijsman, 1982 [6]; Goldstein and Malec, 1989 [7]; *Heinrichs et al, 
1992 [8]; *Hochhalter et al, 2001 [9]; *Hochhalter and Joseph, 2001 [10]; *Irvine and Mawhinney, 2008 [11]; Kashima et al, 1998 [12]; *Kessels et al, 2007 [13]; Komatsu et al, 2000 [14]; Lennane, 1986 [15]; 
*Mimura et al, 1998 [16]; *Mimura et al, 2005 [17]; *Monteiro et al, 2011 [18]; *Morgan et al, 1990 [19]; *Morrison and Pestell, 2010 [20]; Svanberg and Evans, 2013 [21]; *Van Damme and d’Ydewalle, 2008 [22]; 
*Wilson et al, 1994 [23]; *Wilson et al, 2012 [24]; Woods, 1982 [25].  
N.B. Papers marked * were also reviewed by Svanberg and Evans (2013) 
  
Table 2: Pharmacological treatments for ARBD 
Drug No. of papers  Number of  
Case Studies 
Description of treatment Summary of findings 





2 [1,24] B vitamins include thiamine (B1), riboflavin (B2), 
niacin (B3), folate (B9) and pyridoxine (B6). 
Dietary sources include wholemeal cereals, nuts, 
yeast, pulses, leafy vegetables, liver, chicken, beef, 
fish, pork, dairy products. 
B vitamins can be administered subcutaneously, 
intravenously, or orally. 
B-complex vitamins are essential in the acute treatment of Wernicke-
Korsakoff’s Syndrome. However, no standardised dosage, frequency 
and route of thiamine treatment for WKS exists, and the optimum 
duration of thiamine treatment in the long-term management of 





3 [2,8,13] 1 [8] AChEI inhibits the neurotransmitter acetylcholine 
from breaking down to increase the level and 
duration of its action. 
Donepezil and Rivastigmine are used to treat 
Alzheimer’s disease.  
Donepezil was associated with improved memory, quality of life, and 
wellbeing, whilst   
Rivastigmine had no beneficial impact on cognitive functioning.  
Fluvoxamine 2 [6,14,17] 0 Selective serotonin reuptake inhibitor used to treat 
depression. 
Findings were inconsistent.  
Methylphenidate 1 [18] 0 Norepinephrine-dopamine reuptake inhibitor 
(NDRI) known as Ritalin, which acts as a 
stimulant. 
Methylphenidate associated with improvements in long-term 
memory, although the impact of the drug was not immediate. No 
short-term memory improvements were found. 
Clonidine 1 
 [16] 
0 α2 Adrenergic agonist Clonidine had no advantageous effect on neuropsychological 
measures in comparison to placebo. 
Desglycinamide 
Arginine Vasopressin  
(DGAVP) 
2 [9,10] 0 Neuropeptide which regulates the body’s retention 
of water 




1 [18] 0 Cholinesterase inhibitor Administration of physostigmine alone had no beneficial effect on 




1 [11] 0 Synthetic amino acid precursor which acts on 
neurotransmitters noradrenaline and adrenaline 
DOPS improved performance on the Memory Passage subtest of the 
Wechsler Memory Scale (WMS) only. 




1 [20] 0 NMDA antagonist which blocks glutamate 
receptors 
Memantine was associated with improved performance on the 
MMSE.  
 
Propranolol 1 [25] 0 Sympatholytic non-selective beta blocker Propranol was associated with reduced rage and violent behaviour in 
male with KS. 
Papers: Carota & Schneider, 2005 [1]; Cochrane et al, 2005 [2]; Cook & Thomson, 1997 [3]; Cook, 2000 [4]; Day et al, 2013 [5]; Ferrin, 1993 [6]; Hemmingsen et al, 1983 [7]; Iga et al, 2001 
[8]; Jennekins-Schinkel et al, 1985 [9]; Laczi et al, 1983 [10]; Langlais et al, 1988 [11]; Leigh et al, 1981 [12]; Luykx et al, 2008 [13]; Martin et al, 1989 [14]; McIntosh et al, 2005 [15]; 
O’Carroll et al, 1993 [16]; O’Carroll et al, 1994 [17]; O’Donnell et al, 1986 [18]; Reuster et al, 2003 [19]; Rustembegovic et al, 2003 [20]; Sum et al, 2012 [21]; Thomson et al, 2012a [22]; 
Thomson et al, 2012b [23]; Yudofsky et al, 1984 [24]. 
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